Summary
Down‐regulated miR‐223‐3p was found in rheumatoid arthritis. This study aimed to further explore the level and role of miR‐223‐3p in gout arthritis (GA). After monosodium urate (MSU)‐induced GA rat and fibroblast‐like synoviocytes (FLSs) models were established, the rat paw volume and gait score were documented and the FLSs were transfected with miR‐223‐3p mimic/inhibitor or NLR family pyrin domain containing 3 (NLRP3) over‐expression plasmids. The MiR‐223‐3p target was found through bioinformatics and the dual‐luciferase reporter. The rat joint pathological damage was observed by hematoxylin and eosin staining. The levels of interleukin (IL)‐1β, tumor necrosis factor (TNF)‐α and articular elastase in rats were detected by enzyme‐linked immunosorbent assay (ELISA). The viability and pyroptosis of FLSs were detected by methyl thiazolyl tetrazolium (MTT) and flow cytometry. The expressions of miR‐223‐3p, NLRP3, cleaved caspase‐1, IL‐1β, apoptosis‐associated speck‐like protein (AS) and cleaved N‐terminal gasdermin D (GSDMD) in FLSs or rat synovial tissues were detected by reverse transcription–quantitative polymerase chain reaction (RT‐qPCR), immunofluorescence, Western blot or immunohistochemistry analysis. MSU increased the paw volume, gait score, inflammation in synovial tissues and increased the levels of IL‐1β, TNF‐α and articular elastase in rats. MSU decreased the viability and increased the pyroptosis of FLSs, up‐regulated the expression of NLRP3, ASC, cleaved caspase‐1, cleaved N‐terminal GSDM, and IL‐1β, and down‐regulated miR‐223‐3p expression in synovial tissues of rat joints and FLSs. MiR‐223‐3p mimic reversed the effect of MSU on lowering cell viability, increasing pyroptosis in FLSs, while miR‐223‐3p inhibitor further enhanced the effect of MSU on FLSs. NLRP3 was a target of miR‐223‐3p. Also, NLRP3 over‐expression reversed the effects of miR‐223‐3p on MSU‐induced FLSs. MiR‐223‐3p inhibited pyroptosis in MSU‐induced rats and FLSs by targeting NLRP3.